Saturday 17 October 2026
Export LFVN’s income statement to Excel — free account
Lifevantage Corporation
LFVN Consumer Defensive Packaged Foods
Lifevantage Corporation’s revenue for fiscal 2026 (year ended June 2026) was $182.6 million, down 20.1% from fiscal 2025. In the quarter to June 2026, revenue fell 23.1%, EPS fell 37.5% and free cash flow grew 346.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.00
0.00
0.00%
Follow LFVN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
15.60 | 9.39 | 9.78 | 11.87 |
+8 more quarters Free account |
P/S ratio |
0.43 | 0.28 | 0.37 | 0.53 | |
P/FCF ratio |
12.52 | 16.27 | 61.18 | 14.58 | |
P/Operating CF |
16.41 | 10.93 | 27.90 | (52.34) | |
P/B ratio |
2.33 | 1.64 | 2.36 | 3.64 | |
Price to Tangible BV |
2.60 | 1.84 | 2.67 | 3.67 | |
EV/Sales |
0.36 | 0.23 | 0.34 | 0.48 | |
EV/EBITDA |
7.43 | 4.76 | 5.93 | 7.41 | |
EV/Operating CF |
6.46 | 6.91 | 18.84 | 10.88 | |
EV/FCF |
10.60 | 13.41 | 55.47 | 13.35 | |
Quick Ratio |
0.95 | 0.85 | 0.80 | 1.11 | |
Current Ratio |
1.89 | 1.96 | 2.03 | 2.39 | |
Net Debt/EBITDA |
(6.28) | (5.20) | (8.15) | (4.54) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
2.72 | 2.80 | 3.24 | 3.72 | |
Operating CF/Net income |
3.73 | 3.66 | 10.11 | (1.07) | |
Capex/Depreciation |
(1.46) | (1.40) | (1.42) | (0.71) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
74.04% | 75.18% | 73.00% | 74.74% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.00 | |
Share Based Compensation of Revenue |
0.62% | 1.61% | 1.13% | 1.74% | |
Graham Net Nets |
0.13 | 0.19 | 0.13 | 0.14 | |
Graham Number |
4.91 | 5.23 | 6.08 | 7.02 | |
Earnings Yield |
6.41% | 10.65% | 10.23% | 8.43% | |
Free Cash Flow Yield |
7.99% | 6.15% | 1.63% | 6.86% | |
Revenue per Share |
3.38 | 3.46 | 3.87 | 3.84 | |
Operating CF per Share |
0.38 | 0.40 | 0.22 | (0.19) | |
Capex per Share |
(0.08) | (0.08) | (0.09) | (0.04) | |
Free Cash Flow per Share |
0.30 | 0.32 | 0.14 | (0.22) | |
Cash per Share |
1.19 | 0.99 | 0.81 | 1.06 | |
Shareholders Equity per Share |
2.68 | 2.64 | 2.61 | 2.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.68 | 2.64 | 2.61 | 2.67 | |
Free Cash Flow |
3.73 | 3.98 | 1.71 | (2.74) | |
Working Capital |
18.07 | 19.21 | 19.54 | 26.22 | |
Capital Expenditures |
(1.04) | (1.01) | (1.08) | (0.44) | |
Net Current Asset Value |
9.78 | 10.53 | 10.38 | 16.63 | |
EV/EBIT |
10.85 | 6.83 | 7.88 | 9.28 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Price to Operating Income |
12.82 | 8.29 | 8.70 | 10.14 | |
| Other line items | |||||
Average Receivables |
4.15 | 3.93 | 3.53 | 5.79 | |
Average Payables |
4.88 | 6.09 | 5.32 | 4.81 | |
Average Inventory |
18.42 | 20.30 | 18.22 | 18.75 | |
Average Assets |
67.03 | 69.68 | 64.85 | 61.52 | |
Average Common Equity |
34.12 | 33.68 | 31.44 | 30.43 |
Columns are period end dates